相关实验视频
Updated: Sep 13, 2025

11:15
HKUST-1 as a Heterogeneous Catalyst for the Synthesis of Vanillin
Published on: July 23, 2016
10.3K
瓦尼林:作为抗炎剂的治疗潜力的审查
Sonia Singh1, Bhupesh Chander Semwal1, Bhoopendra Singh2
1Institute of Pharmaceutical Research, GLA University, 17km Stone, NH-2, Mathura-Delhi Road Mathura, Chaumuhan, Uttar Pradesh, 281406, India.
Recent advances in inflammation & allergy drug discovery
|July 31, 2025
概括
香草中发现的香草素表现出抗炎,抗氧化和抗癌的特性. 本综述探讨了它在药物研究中的治疗潜力及其对疾病信号通路的影响.
科学领域:
- 植物化学 植物化学
- 药理学 药理学是指药理学的学科.
- 药用化学 医学化学
背景情况:
- 瓦尼林是一种来自植物的天然化合物,广泛用于食品,化品和制药.
- 它具有显著的抗炎,抗氧化和抗癌特性.
- 瓦尼林是有价值化学品的前体,并被研究用于疾病治疗.
研究的目的:
- 提供瓦尼林药理学效应的全面审查.
- 阐明香草素对各种疾病相关信号通路的影响.
- 讨论其药理动力学概况和临床试验数据.
主要方法:
- 对素现有研究的文献综述.
- 对香草素在疾病途径中的作用机制的分析.
- 检查药物动力学数据和临床试验结果.
主要成果:
- 瓦尼林表现出强大的抗炎,抗氧化和抗癌活性.
- 它的植物化学特性影响了参与疾病的关键信号通路.
- 药理动力学研究和临床试验支持其治疗潜力.
结论:
- 瓦尼林是一种有前途的植物化学物质,具有多种治疗应用.
- 进一步研究瓦尼林的信号通路相互作用是有必要的.
- 瓦尼林有潜力开发用于治疗各种疾病的新药.
更多相关视频
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
368
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
368
Inflammation
55.2K
Overview
55.2K
Therapeutic Index
5.1K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
5.1K
Inflammatory Bowel Disease IV: Pharmacological Management
193
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
193

